Article
Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention.
Diabetes care - 1 Feb 2026
You Lu, Parikh Hemang M, Triolo Taylor M, Ferrat Lauric A, Templeman Erin L, Oram Richard A, Gottlieb Peter A, Rich Stephen S, Onengut-Gumuscu Suna, Steck Andrea K, Krischer Jeffrey, Redondo Maria J
Abstract excerpt
OBJECTIVE: The TrialNet Oral Insulin Prevention Trial TN07 tested oral insulin to prevent stage 3 type 1 diabetes (T1D) in 560 relatives with stage 1 T1D of individuals with T1D. Of the three predefined risk strata, participants in secondary stratum 1 (SS1) (n = 55), characterized by low first-phase insulin release, responded significantly better to oral insulin. We aimed to identify genetic factors associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
